Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Founder and CEO of FinCEN REPORT, Jonathan B. Wilson, will be speaking at a Shenkman Law webinar on December 18, 2023, to discuss how lawyers, accountants, and other advisors can address the CTA...
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Leaders and influencers convened at the 8th International Conference on Waste to Worth to address the imperative shift towards a circular economy. The event, virtually graced by Shri Hardeep Singh...
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company along...
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced that it will be joining 14 other companies in...
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
A report from Science and Technology Daily: The opening ceremony of the 2023 World 5G Convention, themed "5G+ By All For All," was held in Zhengzhou, central China's Henan province, on December 6....
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
CTO Pierre Craen Presents and Company Will Demonstrate TLens® and TWedge® in Booth # 5336 HORTEN, Norway, Dec. 6, 2023 /PRNewswire/ -- poLight ASA (OSE: PLT) announced that Chief Technology Officer
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Wei Xue, Vice President of TCL Technology and Chairman of the TCL Charity Foundation, represented the company as a keynote speaker at a side event on 4 December, focused on the role of sustainable...
-
Dec 5, 2023Virtual Press Office and PR Newswire: General Trade show news
SystImmune, Inc (SystImmune), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) authorized the company to proceed with the planned clinical...
-
Dec 5, 2023Virtual Press Office and PR Newswire: General Trade show news
BetMGM, LLC ("BetMGM"), one of the leading sports betting and iGaming operators across the U.S., jointly owned by MGM Resorts International (NYSE: MGM) ("MGM Resorts") and Entain plc (LSE: ENT)...
-
Dec 5, 2023Virtual Press Office and PR Newswire: General Trade show news
Company Today Also Provided Updates on R&D Portfolio and Strategy at Investor Event Crinecerfont New Drug Application Submission Planned in 2024 NBI-'770, an Oral NMDA NR2B Negative Allosteric...